Dr. Anuja Vyas, MD

Dr. Vyas practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Vyas' NPI, 1316171283, was assigned on May 7, 2009. Dr. Vyas graduated from N.H.L Municipal Medical College in 2008. Dr. Vyas holds California license A125136.

Dr. Vyas' primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Vyas' primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Vyas is also affiliated with Sharp Memorial Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Vyas to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vyas practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Vyas' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Vyas is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Vyas is licensed in California.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic sinusitis, pleural effusion, pneumonia, pulmonary fibrosis, pulmonary heart disease and sleep apnea among the conditions Dr. Vyas treats.

CMS data shows 449 Medicare services from Dr. Vyas across 12 procedure codes in 2024, for 196 Medicare patients. Medicare paid $40,802 for them.

CMS counts 196 Medicare patients who saw Dr. Vyas in 2024. The largest group is 75 to 84, with 82 patients. 72% of them have high blood pressure, and 71% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vyas' median patient age at 64, with 47% women.

In 2024, Dr. Vyas wrote 607 Medicare Part D claims for 110 patients. 49% of them were for generic drugs. CMS names the drug for 479 of them, across 19 drugs with 11 or more claims each, at $353,218 in total drug cost. In 2023, CMS named 586 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Vyas for performance year 2024, reported as part of a group. Dr. Vyas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vyas as offering telehealth.

Dmand AI links 4 papers to Dr. Vyas, published from 2017 to 2020. Dr. Vyas' most frequent co-authors are Atul Malhotra, MD, Haritha Ackula, MBBS and William Roger Auger, MD.

CMS Open Payments shows 42 general payments to Dr. Vyas from 9 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Intuitive Surgical, Inc. paid the most, $34,172.

Dr. Vyas graduated from N.H.L Municipal Medical College in 2008. Dr. Vyas is a member of ACCP and ATS.

Dr. Vyas is in network with 6 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.